from what you guys are stating, I'm thinking that $60 is doable in the near term. imagine if the time comes when both pona and 113 have been approved and are being regularly used for treatment in front lines? who knows how high the price could go! Harvey might consider that before selling under a $100 to big pharma.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.